Compare Cytokinetics Inc (CYTK) vs Matson Inc (MATX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs Matson Inc — how do they compare? Cytokinetics Inc trades at $76.61 (market cap $10.63B), while Matson Inc trades at $204.71 (market cap $6.11B). The key difference: Cytokinetics Inc is the larger of the two by market cap, and Matson Inc pays a 0.74% dividend while Cytokinetics Inc pays none. Which is the better fit depends on your goals.
| CYTK | MATX | |
|---|---|---|
Market Cap | $10.63B | $6.11B |
Sector | Technology | Technology |
52-Week High | $87.26 | $223.55 |
52-Week Low | $34.31 | $88.05 |
Enterprise Value | $10.74B | $6.71B |
Dividend Yield | — | 0.74% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About Matson Inc
Matson, Inc. is an American shipping and logistics company primarily operating in the Pacific. The company provides ocean transportation services, including container, automobile, and general cargo, particularly between the U.S. West Coast, Hawaii, Alaska, and Guam. Matson also offers logistics services, including warehousing, less-than-container load (LCL) consolidation, and supply chain management, making it a critical service provider for businesses operating across the Pacific region.
Read more on MATX →
